Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Vector Laboratories

Vector Laboratories
1976 FOUNDED
M&A STATUS
Debt LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Developer and manufacturer of labeling and detection reagents. The company specializes in developing labeling and detection reagents which are critical components in immunohistochemistry studies and other life science research applications, enabling researchers at leading hospitals, academic research institutions and life science companies to receive new formulations of curing antifade mounting media for immunofluorescence applications that overcome many of the issues experienced with other setting antifade media.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Parent Company
Primary Office
  • 30 Ingold Road
  • Burlingame, CA 94010
  • United States

+1 (650) 000-0000

Vector Laboratories Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Vector Laboratories‘s full profile, request access.

Request full access to PitchBook

Vector Laboratories Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cell Signaling Technology Corporation Danvers, MA
00000 0000 0000000 Private Equity-Backed Irving, TX 000 00000 000000000 00000
00 000 00000000000 Corporate Backed or Acquired Carlsbad, CA 00 000000&0
00000000 000000000 Formerly VC-backed Newark, CA 000000&0
000000000 Corporation San Diego, CA 000
To view this company’s complete list of competitors, request access »

Vector Laboratories Executive Team (4)

Name Title Board
Seat
Contact
Info
Carl Hull Chief Executive Officer
David Weber Vice President & Chief Commercial Officer

2 Former Executives

You’re viewing 2 of 4 executives. Get the full list »